The Efficacy of Topical Sucralfate for Skin Ulcer: A Systematic Review of Randomized Control Trials and Cohort Studies
Main Article Content
Wound care in ulcers often poses significant challenges due to prolonged healing time and frequently unsatisfactory outcomes. The use of topical modalities to maintain a moist wound environment continues to be developed. Sucralfate, as a cytoprotective agent for gastric mucosa, has shown potential in the management of ulcers. This systematic review aims to determine the efficacy of topical sucralfate in ulcer wound healing. A comprehensive literature search was conducted across databases including PubMed and Google Scholar, for nine clinical studies published between 2008 and 2023 across multiple countries. The present study included randomized controlled trials (RCTs) and cohort studies that compared sucralfate dressing with conventional dressing. Outcomes of interest included reduction area, healing time, healing rate, and rate of granulation tissue formation. Nine studies fulfilled the eligibility criteria, assigning topical sucralfate as the intervention and conventional modalities (saline, mupirocin, povidone iodine) or placebo as comparators. The study duration ranged from 10 days to 3 months, during which topical sucralfate achieved superior outcomes, with a statistically significant reduction in healing time and greater wound area reduction compared with controls. These results indicate that topical sucralfate is effective in ulcer wound management, exerting cytoprotective effects and promoting epithelial regeneration, thereby enhancing the overall quality of wound healing. While primarily considered an adjunctive agent, the evidence demonstrates that sucralfate exerts clinically relevant effects on epithelialization and tissue recovery. Its cytoprotective properties underscore a therapeutic role that extends beyond supportive care, reinforcing its value as a complementary strategy in wound management.
Bhatmule, A., Janugade, H. B., & Nangare, N. (2022). A competitive study of topical sucralfate and ordinary saline for diabetic ulcer dressing. Journal of Pharmaceutical Negative Results, 577–580. https://doi.org/10.47750/pnr.2022.13.s06.081
Chatterjee, N., Ekka, N. M., Mahajan, M., Kumar, B., Kumar, N., Zia, A., Devarajan, A., Kujur, A. D., & Sinha, D. K. (2023). Effectiveness of topical sucralfate in the management of diabetic foot ulcers: An open-labeled randomized study. Cureus. https://doi.org/10.7759/cureus.37570
Chatterjee, S., Sen, S., Hazra, A., & Das, A. (2019). Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers. Indian Journal of Pharmacology, 51(5), 316–322. https://doi.org/10.4103/ijp.IJP_237_17
Fernandes, A., Luciana, P., & Lastória, S. (2005). Venous ulcer: Epidemiology, physiopathology, diagnosis and treatment. International Journal of Dermatology, 44.
Gudigar, J. S., Arif, M., Kumar, D., & Karlekar, M. V. (2022). A comparative study of the topical use of phenytoin and sucralfate in chronic ulcers at a tertiary care hospital. Journal of Cardiovascular Disease Research, 13(4).
Kolimi, P., Narala, S., Nyavanandi, D., Youssef, A. A. A., & Dudhipala, N. (2022). Innovative treatment strategies to accelerate wound healing: Trajectory and recent advancements. Cells, 11(15), 2439.
Masuelli, L., Tumino, G., Turriziani, M., Modesti, A., & Bei, R. (2010). Topical use of sucralfate in epithelial wound healing: Clinical evidence and molecular mechanisms of action. Recent Patents on Inflammation & Allergy Drug Discovery, 4.
Panuncialman, J., & Falanga, V. (2010). Unusual causes of cutaneous ulceration. Surgical Clinics of North America, 90(6), 1161–1180. https://doi.org/10.1016/j.suc.2010.08.006
Prabhakar, S., Graduate, P., & Professor, A. (2017). Comparative study between phenytoin and sucralfate dressing in diabetic foot ulcers. MedPulse International Journal of Surgery, 3(1), 3. https://doi.org/10.26611/1063111
Preethi, S., & Dhanasekaran, V. (2019). Comparative study of efficacy and cost effectiveness of topical sucralfate and conventional dressings in diabetic ulcers. International Journal of Surgery Science, 4(4), 435–438.
Saifullah, Q., & Sharma, A. (2024). Current trends on innovative technologies in topical wound care for advanced healing and management. Current Drug Research Reviews, 16(3), 319–332.
Simanjuntak, V. J. S., Yuniati, R., & Prajoko, Y. W. (2023). Effectiveness of sucralfate and platelet-rich plasma combinations for vascular endothelial growth factor (VEGF) expression in diabetic ulcer healing. Journal of Clinical Medicine, 10(3), 359–363.
Sorg, H., Tilkorn, D. J., Hager, S., Hauser, J., & Mirastschijski, U. (2017). Skin wound healing: An update on the current knowledge and concepts. European Surgical Research, 58(1–2), 81–94. https://doi.org/10.1159/000454919
Tumino, G., Masuelli, L., Bei, R., Simonelli, L., Santoro, A., & Francipane, S. (2008). Topical treatment of chronic venous ulcers with sucralfate: A placebo-controlled randomized study. International Journal of Molecular Medicine, 22, 17–23.
Weigelt, M. A., Lev-Tov, H. A., Tomic-Canic, M., Lee, W. D., Williams, R., Strasfeld, D., Kirsner, R. S., & Herman, I. M. (2022). Advanced wound diagnostics: Toward transforming wound care into precision medicine. Advances in Wound Care, 11(6), 330–359.
Zuniga, J., Mungai, M., Chism, L., Frost, L., Kakkar, R., & Kyololo, O. B. (2024). Pressure ulcer prevention and treatment interventions in Sub-Saharan Africa: A systematic review. Nursing Outlook, 72(3). https://doi.org/10.1016/j.outlook.2024.102151
